Trade WHWK stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Whitehawk Therapeutics, Inc. (WHWK) is trading at US$4.09, up 0.49% today as of Sep 15, 16:00 EDT. The company has a market capitalisation of US$269.65M. Over the past 52 weeks, WHWK has traded between US$1.82 and US$5.50. On Syfe you can trade WHWK with $0 commission and add it to your watchlist.
| Previous close | US$4.07 |
|---|---|
| Market cap | US$269.65M |
| 52-week range | US$1.82 – US$5.50 |
| Volume | 142.34K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.
Year: 2021
--Leerink Partners Initiates Coverage on Whitehawk Therapeutics With Outperform Rating, $9 PT
Jul 13, 11:37 AM · MT Newswires
B. Riley Initiates Whitehawk Therapeutics at Buy With $10 Price Target
Jun 25, 11:40 AM · MT Newswires
Whitehawk Therapeutics' Antibody Drug Conjugates Indicate Potential Efficacy Against Cancer, Oppenheimer Says
Apr 21, 3:56 PM · MT Newswires
Whitehawk Therapeutics, Inc. (WHWK) stock is trading at US$4.09, +0.49% from the previous close of US$4.07.
The market cap for Whitehawk Therapeutics, Inc. (WHWK) stock is approximately US$269.65M.
The 52-week high for Whitehawk Therapeutics, Inc. (WHWK) stock is US$5.50.
The 52-week low for Whitehawk Therapeutics, Inc. (WHWK) stock is US$1.82.
Whitehawk Therapeutics, Inc. (WHWK) does not currently pay a dividend.
Stay on top of WHWK
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
